Sponsor Pipeline

Guangzhou Xiling Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07259889 Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors Advanced Solid Tumors (Phase 1) Recruiting
Get alerts when Guangzhou Xiling Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free